Primo N Lara

12PUBLICATIONS
163CO-AUTHORS
Molecular targetsComparative language studiesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 02, 2026
A Phase I trial of PLZ4-coated paclitaxel-loaded micelles in patients with refractory non-muscle-invasive bladder cancer.

|Apr 20, 2026
Capturing Latino Health Disparities: Lessons from Mail- and Community-Based Population Health Surveys in California.

|Nov 18, 2025
Systemic Therapy for Muscle-Invasive Urothelial Carcinoma of the Bladder (Muscle-Invasive Bladder Cancer): Insights From Real-World Data.

Sarmad Sadeghi, Primo N Lara, Andrea Necchi

|Oct 17, 2025
The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404).

Mamta Parikh, Nataliya V Uboha, Naoko Takebe

|Sep 10, 2024
Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma.

Pedro Barata, Catherine Tangen, Melissa Plets

|Jul 02, 2024
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors.

Andrea B Apolo, Daniel M Girardi, Scot A Niglio

Pageof 2

Frequent Collaborators

3 joint publications

Sumanta Pal

3 joint publications

David Quinn

2 joint publications

Catherine Tangen

2 joint publications

Mark Stein